Trials / Unknown
UnknownNCT01968616
Ranibizumab Treatment for Retinal Vein Occlusion
Predictive Factors of 2-year Visual Outcome in Retinal Vein Occlusion Following Intravitreal Ranibizumab Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Kyoto University, Graduate School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In retinal vein occlusion, predictive factors for visual outcome after ranibizumab treatment have not been evaluated comprehensively. Therefore, we have planned to analyze predictors for visual outcome from a viewpoint of electrophysiology and biomarkers besides morphological features by SD-OCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ranibizumab, 0.5mg, Intravitreal |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2013-10-24
- Last updated
- 2017-03-10
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01968616. Inclusion in this directory is not an endorsement.